The impact of the COVID-19 epidemic on hospital admissions for alcohol-related liver disease and pancreatitis in Japan

Abstract During the coronavirus disease 2019 (COVID-19) pandemic, there have been health concerns related to alcohol use and misuse. We aimed to examine the population-level change in cases of alcohol-related liver disease and pancreatitis that required admission during the COVID-19 epidemic by inte...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hisashi Itoshima, Jung-ho Shin, Daisuke Takada, Tetsuji Morishita, Susumu Kunisawa, Yuichi Imanaka
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/bd3baf865e254407bc3e893fdba60a90
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bd3baf865e254407bc3e893fdba60a90
record_format dspace
spelling oai:doaj.org-article:bd3baf865e254407bc3e893fdba60a902021-12-02T16:14:02ZThe impact of the COVID-19 epidemic on hospital admissions for alcohol-related liver disease and pancreatitis in Japan10.1038/s41598-021-92612-22045-2322https://doaj.org/article/bd3baf865e254407bc3e893fdba60a902021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-92612-2https://doaj.org/toc/2045-2322Abstract During the coronavirus disease 2019 (COVID-19) pandemic, there have been health concerns related to alcohol use and misuse. We aimed to examine the population-level change in cases of alcohol-related liver disease and pancreatitis that required admission during the COVID-19 epidemic by interrupted time series (ITS) analysis using claims data. We defined the period from April 2020, when the Japanese government declared a state of emergency, as the beginning of the COVID-19 epidemic. This ITS analysis included 3,026,389 overall admissions and 10,242 admissions for alcohol-related liver disease or pancreatitis from 257 hospitals between July 2018 and June 2020. The rate of admissions per 1000 admissions during the COVID-19 epidemic period (April 2020–June 2020) was 1.2 times (rate ratio: 1.22, 95% confidence interval: 1.12–1.33) compared to the pre-epidemic period. Analyses stratified by sex revealed that the increases in admission rates of alcohol-related liver disease or pancreatitis for females were higher than for males during the COVID-19 epidemic period. The COVID-19 epidemic in Japan might associates an increase in hospital admissions for alcohol-related liver disease and pancreatitis. Our study could support the concern of alcohol consumption and health problems during the COVID-19 pandemic.Hisashi ItoshimaJung-ho ShinDaisuke TakadaTetsuji MorishitaSusumu KunisawaYuichi ImanakaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Hisashi Itoshima
Jung-ho Shin
Daisuke Takada
Tetsuji Morishita
Susumu Kunisawa
Yuichi Imanaka
The impact of the COVID-19 epidemic on hospital admissions for alcohol-related liver disease and pancreatitis in Japan
description Abstract During the coronavirus disease 2019 (COVID-19) pandemic, there have been health concerns related to alcohol use and misuse. We aimed to examine the population-level change in cases of alcohol-related liver disease and pancreatitis that required admission during the COVID-19 epidemic by interrupted time series (ITS) analysis using claims data. We defined the period from April 2020, when the Japanese government declared a state of emergency, as the beginning of the COVID-19 epidemic. This ITS analysis included 3,026,389 overall admissions and 10,242 admissions for alcohol-related liver disease or pancreatitis from 257 hospitals between July 2018 and June 2020. The rate of admissions per 1000 admissions during the COVID-19 epidemic period (April 2020–June 2020) was 1.2 times (rate ratio: 1.22, 95% confidence interval: 1.12–1.33) compared to the pre-epidemic period. Analyses stratified by sex revealed that the increases in admission rates of alcohol-related liver disease or pancreatitis for females were higher than for males during the COVID-19 epidemic period. The COVID-19 epidemic in Japan might associates an increase in hospital admissions for alcohol-related liver disease and pancreatitis. Our study could support the concern of alcohol consumption and health problems during the COVID-19 pandemic.
format article
author Hisashi Itoshima
Jung-ho Shin
Daisuke Takada
Tetsuji Morishita
Susumu Kunisawa
Yuichi Imanaka
author_facet Hisashi Itoshima
Jung-ho Shin
Daisuke Takada
Tetsuji Morishita
Susumu Kunisawa
Yuichi Imanaka
author_sort Hisashi Itoshima
title The impact of the COVID-19 epidemic on hospital admissions for alcohol-related liver disease and pancreatitis in Japan
title_short The impact of the COVID-19 epidemic on hospital admissions for alcohol-related liver disease and pancreatitis in Japan
title_full The impact of the COVID-19 epidemic on hospital admissions for alcohol-related liver disease and pancreatitis in Japan
title_fullStr The impact of the COVID-19 epidemic on hospital admissions for alcohol-related liver disease and pancreatitis in Japan
title_full_unstemmed The impact of the COVID-19 epidemic on hospital admissions for alcohol-related liver disease and pancreatitis in Japan
title_sort impact of the covid-19 epidemic on hospital admissions for alcohol-related liver disease and pancreatitis in japan
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/bd3baf865e254407bc3e893fdba60a90
work_keys_str_mv AT hisashiitoshima theimpactofthecovid19epidemiconhospitaladmissionsforalcoholrelatedliverdiseaseandpancreatitisinjapan
AT junghoshin theimpactofthecovid19epidemiconhospitaladmissionsforalcoholrelatedliverdiseaseandpancreatitisinjapan
AT daisuketakada theimpactofthecovid19epidemiconhospitaladmissionsforalcoholrelatedliverdiseaseandpancreatitisinjapan
AT tetsujimorishita theimpactofthecovid19epidemiconhospitaladmissionsforalcoholrelatedliverdiseaseandpancreatitisinjapan
AT susumukunisawa theimpactofthecovid19epidemiconhospitaladmissionsforalcoholrelatedliverdiseaseandpancreatitisinjapan
AT yuichiimanaka theimpactofthecovid19epidemiconhospitaladmissionsforalcoholrelatedliverdiseaseandpancreatitisinjapan
AT hisashiitoshima impactofthecovid19epidemiconhospitaladmissionsforalcoholrelatedliverdiseaseandpancreatitisinjapan
AT junghoshin impactofthecovid19epidemiconhospitaladmissionsforalcoholrelatedliverdiseaseandpancreatitisinjapan
AT daisuketakada impactofthecovid19epidemiconhospitaladmissionsforalcoholrelatedliverdiseaseandpancreatitisinjapan
AT tetsujimorishita impactofthecovid19epidemiconhospitaladmissionsforalcoholrelatedliverdiseaseandpancreatitisinjapan
AT susumukunisawa impactofthecovid19epidemiconhospitaladmissionsforalcoholrelatedliverdiseaseandpancreatitisinjapan
AT yuichiimanaka impactofthecovid19epidemiconhospitaladmissionsforalcoholrelatedliverdiseaseandpancreatitisinjapan
_version_ 1718384372311130112